G. Yavas Et Al. , "Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer," CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.6, pp.801-802, 2018
Yavas, G. Et Al. 2018. Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.6 , 801-802.
Yavas, G., Yavas, C., & AKYÜREK, S., (2018). Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.6, 801-802.
Yavas, G., C. Yavas, And SERAP AKYÜREK. "Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer," CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.6, 801-802, 2018
Yavas, G. Et Al. "Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.6, pp.801-802, 2018
Yavas, G. Yavas, C. And AKYÜREK, S. (2018) . "Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.20, no.6, pp.801-802.
@article{article, author={G. Yavas Et Al. }, title={Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer}, journal={CLINICAL & TRANSLATIONAL ONCOLOGY}, year=2018, pages={801-802} }